1887

Chapter 28 : Epstein-Barr Virus

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Epstein-Barr Virus, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819156/9781555819149.ch28-1.gif /docserver/preview/fulltext/10.1128/9781555819156/9781555819149.ch28-2.gif

Abstract:

In 1964, three researchers, Michael Anthony Epstein, Bert Achong, and Yvonne Barr, published in their discovery of what would later be known as Epstein-Barr virus (EBV) (1). Before this breakthrough, Epstein had been studying chicken tumor viruses at the Middlesex Hospital in London. In 1961, Epstein attended a lecture by Denis P. Burkitt, a British surgeon who had been stationed in Uganda, in which he detailed the relationship between Burkitt lymphoma and the geographical patterns of temperature, rainfall, and altitude (2). Suspicious of a viral etiology, Epstein spent the next few years attempting to isolate viral material from lymphoma biopsy samples taken from tumors of Ugandan children sent weekly by Burkitt to London. Despite a switch to tissue culture and assistance from Yvonne Barr and Bert Achong, isolation of a virus was unsuccessful. On December 5, 1963, the sample sent by Burkitt was delayed due to inclement weather, which fortuitously resulted in viable, free-floating, lymphoma cells that astonishingly grew in culture and demonstrated viral particles by electron microscopy (1). Though this initial finding was met with skepticism, mounting evidence over the following decades eventually resulted in the acceptance of EBV as the cause of Burkitt lymphoma, and the World Health Organization and the International Agency for Research and Cancer declared EBV as a group 1 carcinogen in the 1990s (2). Approximately 90% of people worldwide are carriers of latent EBV, and it is estimated that the virus causes more than 200,000 cancers each year, primarily B-cell neoplasms, which account for 1.5% of all cancers (2). There are two types of EBV, EBV-1 (A type) and EBV-2 (B type), that are distinguished by differences found primarily in their latent genes. EBV in America and Europe are much more likely to be EBV-1, whereas EBV found in Africa may be EBV-1 or EBV-2.

Citation: Chen D, Yen-Lieberman B. 2016. Epstein-Barr Virus, p 387-398. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch28
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555819156.ch28
1. Epstein MA, Achong BG, Barr YM. 1964. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1:702703.[PubMed]
2. Holmes D. 2014. The cancer-virus cures. Nat Med 20:571574.[PubMed]
3. Shannon-Lowe C, Rowe M. 2014. Epstein Barr virus entry; kissing and conjugation. Curr Opin Virol 4:7884.[PubMed]
4. Thorley-Lawson DA, Gross A. 2004. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350:13281337.[PubMed]
5. Balfour HH Jr, Sifakis F, Sliman JA, Knight JA, Schmeling DO, Thomas W. 2013. Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6–19 years in the United States and factors affecting its acquisition. J Infect Dis 208:12861293.[PubMed]
6. Cohen JI. 2000. Epstein-Barr virus infection. N Engl J Med 343:481492.[PubMed]
7. Vetsika EK, Callan M. 2004. Infectious mononucleosis and Epstein-Barr virus. Expert Rev Mol Med 6:116.[PubMed]
8. Di Lernia V, Mansouri Y. 2013. Epstein-Barr virus and skin manifestations in childhood. Int J Dermatol 52:11771184.[PubMed]
9. Smellie WS, Forth J, Smart SR, Galloway MJ, Irving W, Bareford D, Collinson PO, Kerr KG, Summerfield G, Carey PJ, Minhas R. 2007. Best practice in primary care pathology: review 7. J Clin Pathol 60:458465.[PubMed]
10. Ebell MH. 2004. Epstein-Barr virus infectious mononucleosis. Am Fam Physician 70:12791287.[PubMed]
11. Kimura H. 2006. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol 16:251261.[PubMed]
12. Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, Morio T, Mori M, Yokota S, Imashuku S. 2005. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 80:6469.[PubMed]
13. Maakaroun NR, Moanna A, Jacob JT, Albrecht H. 2010. Viral infections associated with haemophagocytic syndrome. Rev Med Virol 20:93105.[PubMed]
14. Henter JI, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. 2007. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124131.[PubMed]
15. Veillette A, Pérez-Quintero LA, Latour S. 2013. X-linked lymphoproliferative syndromes and related autosomal recessive disorders. Curr Opin Allergy Clin Immunol 13:614622.[PubMed]
16. Rezaei N, Mahmoudi E, Aghamohammadi A, Das R, Nichols KE. 2011. X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma. Br J Haematol 152:1330.[PubMed]
17. Woon ST, Ameratunga R, Croxson M, Taylor G, Neas K, Edkins E, Browett P, Gane E, Munn S. 2008. Follicular lymphoma in a X-linked lymphoproliferative syndrome carrier female. Scand J Immunol 68:153158.[PubMed]
18. Marsh RA, Madden L, Kitchen BJ, Mody R, McClimon B, Jordan MB, Bleesing JJ, Zhang K, Filipovich AH. 2010. XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood 116:10791082.[PubMed]
19. Filipovich AH, Zhang K, Snow AL, Marsh RA. 2010. X-linked lymphoproliferative syndromes: brothers or distant cousins? Blood 116:33983408.[PubMed]
20. Dunleavy K, Roschewski M, Wilson WH. 2012. Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes. Curr Hematol Malig Rep 7:208215.[PubMed]
21. Green M, Michaels MG. 2013. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant 13(Suppl 3):4154, quiz 54.[PubMed]
22. van Esser JW, van der Holt B, Meijer E, Niesters HG, Trenschel R, Thijsen SF, van Loon AM, Frassoni F, Bacigalupo A, Schaefer UW, Osterhaus AD, Gratama JW, Löwenberg B, Verdonck LF, Cornelissen JJ. 2001. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell—depleted SCT. Blood 98:972978.[PubMed]
23. Allen UD, Preiksaitis JKAST Infectious Diseases Community of Practice. 2013. Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation. Am J Transplant 13(Suppl 4):107120.[PubMed]
24. Gulley ML, Tang W. 2008. Laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn 10:279292.[PubMed]
25. Triantos D, Porter SR, Scully C, Teo CG. 1997. Oral hairy leukoplakia: clinicopathologic features, pathogenesis, diagnosis, and clinical significance. Clin Infect Dis 25:13921396.[PubMed]
26. Braz-Silva PH, de Rezende NP, Ortega KL, de Macedo Santos RT, de Magalhães MH. 2008. Detection of the Epstein-Barr virus (EBV) by in situ hybridization as definitive diagnosis of hairy leukoplakia. Head Neck Pathol 2:1924.[PubMed]
27. Shah KM, Young LS. 2009. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma. Clin Microbiol Infect 15:982988.[PubMed]
28. Colaco RJ, Betts G, Donne A, Swindell R, Yap BK, Sykes AJ, Slevin NJ, Homer JJ, Lee LW. 2013. Nasopharyngeal carcinoma: a retrospective review of demographics, treatment and patient outcome in a single centre. Clin Oncol (R Coll Radiol) 25:171177.[PubMed]
29. Fukayama M, Ushiku T. 2011. Epstein-Barr virus-associated gastric carcinoma. Pathol Res Pract 207:529537.[PubMed]
30. Iizasa H, Nanbo A, Nishikawa J, Jinushi M, Yoshiyama H. 2012. Epstein-Barr Virus (EBV)-associated gastric carcinoma. Viruses 4:34203439.[PubMed]
31. Huo Q, Zhang N, Yang Q. 2012. Epstein-Barr virus infection and sporadic breast cancer risk: a meta-analysis. PLoS One 7:e31656.[PubMed]
32. Jeong AK, Park SB, Kim YM, Ko BK, Yang MJ, Kwon WJ, Lee JH, Weon YC. 2010. Lymphoepithelioma-like carcinoma of the breast. J Ultrasound Med 29:485488.[PubMed]
33. Joshi D, Buehring GC. 2012. Are viruses associated with human breast cancer? Scrutinizing the molecular evidence. Breast Cancer Res Treat 135:115.[PubMed]
34. Massa J, Hamdan A, Simon KC, Bertrand K, Wulf G, Tamimi RM, Ascherio A. 2012. Infectious mononucleosis and risk of breast cancer in a prospective study of women. Cancer Causes Control 23:18931898.[PubMed]
35. Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H. 2010. Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study. Br J Cancer 102:16651669.[PubMed]
36. Sprangers B, Smets S, Sagaert X, Wozniak A, Wollants E, Van Ranst M, Debiec-Rychter M, Sciot R, Vanrenterghem Y, Kuypers DR. 2008. Posttransplant Epstein-Barr virus-associated myogenic tumors: case report and review of the literature. Am J Transplant 8:253258.[PubMed]
37. Deyrup AT. 2008. Epstein-Barr virus-associated epithelial and mesenchymal neoplasms. Hum Pathol 39:473483.[PubMed]
38. Lossius A, Johansen JN, Torkildsen Ø, Vartdal F, Holmøy T. 2012. Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation. Viruses 4:37013730.[PubMed]
39. Tselis A. 2012. Epstein-Barr virus cause of multiple sclerosis. Curr Opin Rheumatol 24:424428.[PubMed]
40. Lucas RM, Hughes AM, Lay ML, Ponsonby AL, Dwyer DE, Taylor BV, Pender MP. 2011. Epstein-Barr virus and multiple sclerosis. J Neurol Neurosurg Psychiatry 82:11421148.[PubMed]
41. Epstein MA. 1976. Epstein-Barr virus—is it time to develop a vaccine program? J Natl Cancer Inst 56:697700.[PubMed]
42. Villegas E, Santiago O, Sorlózano A, Gutierrez J. 2010. New strategies and patent therapeutics in EBV-associated diseases. Mini Rev Med Chem 10:914927.[PubMed]
43. Balfour HH Jr. 2014. Progress, prospects, and problems in Epstein-Barr virus vaccine development. Curr Opin Virol 6:15.[PubMed]
44. Vouloumanou EK, Rafailidis PI, Falagas ME. 2012. Current diagnosis and management of infectious mononucleosis. Curr Opin Hematol 19:1420.[PubMed]
45. Odumade OA, Hogquist KA, Balfour HH Jr. 2011. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev 24:193209.[PubMed]
46. Singer-Leshinsky S. 2012. Pathogenesis, diagnostic testing, and management of mononucleosis. JAAPA 25:5862.[PubMed]
47. Luzuriaga K, Sullivan JL. 2010. Infectious mononucleosis. N Engl J Med 362:19932000.[PubMed]
48. Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, Burbelo PD, Turk SP, Fulton R, Wayne AS, Little RF, Cairo MS, El-Mallawany NK, Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE. 2011. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood 117:58355849.[PubMed]
49. Chandrakasan S, Filipovich AH. 2013. Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment. J Pediatr 163:12531259.[PubMed]
50. Brasileiro CB, Abreu MH, Mesquita RA. 2014. Critical review of topical management of oral hairy leukoplakia. World J Clin Cases 2:253256.[PubMed]
51. Camargo MC, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, Yu J, Sung JJ, Herrera-Goepfert R, Meneses-Gonzalez F, Kijima Y, Natsugoe S, Liao LM, Lissowska J, Kim S, Hu N, Gonzalez CA, Yatabe Y, Koriyama C, Hewitt SM, Akiba S, Gulley ML, Taylor PR, Rabkin CS. 2014. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut 63:236243.[PubMed]
52. Rychert J, Danziger-Isakov L, Yen-Lieberman B, Storch G, Buller R, Sweet SC, Mehta AK, Cheeseman JA, Heeger P, Rosenberg ES, Fishman JA. 2014. Multicenter comparison of laboratory performance in cytomegalovirus and Epstein-Barr virus viral load testing using international standards. Clin Transplant 28:14161423.[PubMed]
53. Abeynayake J, Johnson R, Libiran P, Sahoo MK, Cao H, Bowen R, Chan KC, Le QT, Pinsky BA. 2014. Commutability of the Epstein-Barr virus WHO international standard across two quantitative PCR methods. J Clin Microbiol 52:38023804.[PubMed]
54. Hoagland RJ. 1975. Infectious mononucleosis. Prim Care 2:295307.[PubMed]
55. Wolf DM, Friedrichs I, Toma AG. 2007. Lymphocyte-white blood cell count ratio: a quickly available screening tool to differentiate acute purulent tonsillitis from glandular fever. Arch Otolaryngol Head Neck Surg 133:6164.[PubMed]
56. Biggs TC, Hayes SM, Bird JH, Harries PG, Salib RJ. 2013. Use of the lymphocyte count as a diagnostic screen in adults with suspected Epstein-Barr virus infectious mononucleosis. Laryngoscope 123:24012404.[PubMed]
57. Lennon P, O'Neill JP, Fenton JE, O'Dwyer T. 2010. Challenging the use of the lymphocyte to white cell count ratio in the diagnosis of infectious mononucleosis by analysis of a large cohort of Monospot test results. Clin Otolaryngol 35:397401.[PubMed]
58. Lennon P, O'Neill JP, O'Dwyer T, Fenton JE. 2014. In reference to “use of the lymphocyte count as a diagnostic screen in adults with suspected Epstein-Barr virus infectious mononucleosis.” Laryngoscope 124:E447.[PubMed]
59. Brigden ML, Au S, Thompson S, Brigden S, Doyle P, Tsaparas Y. 1999. Infectious mononucleosis in an outpatient population: diagnostic utility of 2 automated hematology analyzers and the sensitivity and specificity of Hoagland's criteria in heterophile-positive patients. Arch Pathol Lab Med 123:875881.[PubMed]
60. Tsaparas YF, Brigden ML, Mathias R, Thomas E, Raboud J, Doyle PW. 2000. Proportion positive for Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, Toxoplasma, and human immunodeficiency virus types 1 and 2 in heterophile-negative patients with an absolute lymphocytosis or an instrument-generated atypical lymphocyte flag. Arch Pathol Lab Med 124:13241330.[PubMed]
61. Fisher MS Jr, Guerra CG, Hickman JR, Hensley RE, Doe RH, Dunn CD, Hall RB. 1996. Peripheral blood lymphocyte apoptosis: a clue to the diagnosis of acute infectious mononucleosis. Arch Pathol Lab Med 120:951955.[PubMed]
62. Basson V, Sharp AA. 1969. Monospot: a differential slide test for infectious mononucleosis. J Clin Pathol 22:324325.[PubMed]
63. Bruu AL, Hjetland R, Holter E, Mortensen L, Natås O, Petterson W, Skar AG, Skarpaas T, Tjade T, Asjø B. 2000. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol 7:451456.[PubMed]
64. Hurt C, Tammaro D. 2007. Diagnostic evaluation of mononucleosis-like illnesses. Am J Med 120:911.e1e8.
65. Kreuzer C, Nabeck KU, Levy HR, Daghofer E. 2013. Reliability of the Siemens Enzygnost and Novagnost Epstein-Barr virus assays for routine laboratory diagnosis: agreement with clinical diagnosis and comparison with the Merifluor Epstein-Barr virus immunofluorescence assay. BMC Infect Dis 13:260.[PubMed]
66. De Paschale M, Clerici P. 2012. Serological diagnosis of Epstein-Barr virus infection: problems and solutions. World J Virol 1:3143.[PubMed]
67. Klutts JS, Ford BA, Perez NR, Gronowski AM. 2009. Evidence-based approach for interpretation of Epstein-Barr virus serological patterns. J Clin Microbiol 47:32043210.[PubMed]
68. Gärtner B, Preiksaitis JK. 2010. EBV viral load detection in clinical virology. J Clin Virol 48:8290.[PubMed]
69. Dohno S, Maeda A, Ishiura Y, Sato T, Fujieda M, Wakiguchi H. 2010. Diagnosis of infectious mononucleosis caused by Epstein-Barr virus in infants. Pediatr Int 52:536540.[PubMed]
70. Pitetti RD, Laus S, Wadowsky RM. 2003. Clinical evaluation of a quantitative real time polymerase chain reaction assay for diagnosis of primary Epstein-Barr virus infection in children. Pediatr Infect Dis J 22:736739.[PubMed]
71. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (ed). 2008. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. WHO Press, Geneva, Switzerland.
72. Gulley ML, Tang W. 2010. Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder. Clin Microbiol Rev 23:350366.[PubMed]
73. Braz-Silva PH, Santos RT, Schussel JL, Gallottini M. 2014. Oral hairy leukoplakia diagnosis by Epstein-Barr virus in situ hybridization in liquid-based cytology. Cytopathology 25:2126.[PubMed]
74. Liu Y, Huang Q, Liu W, Liu Q, Jia W, Chang E, Chen F, Liu Z, Guo X, Mo H, Chen J, Rao D, Ye W, Cao S, Hong M. 2012. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China. Int J Cancer 131:406416.[PubMed]
75. Ji MF, Huang QH, Yu X, Liu Z, Li X, Zhang LF, Wang P, Xie SH, Rao HL, Fang F, Guo X, Liu Q, Hong MH, Ye W, Zeng YX, Cao SM. 2014. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China. Cancer 120:13531360.[PubMed]
76. Yoshizaki T, Ito M, Murono S, Wakisaka N, Kondo S, Endo K. 2012. Current understanding and management of nasopharyngeal carcinoma. Auris Nasus Larynx 39:137144.[PubMed]
77. Adham M, Greijer AE, Verkuijlen SA, Juwana H, Fleig S, Rachmadi L, Malik O, Kurniawan AN, Roezin A, Gondhowiardjo S, Atmakusumah D, Stevens SJ, Hermani B, Tan IB, Middeldorp JM. 2013. Epstein-Barr virus DNA load in nasopharyngeal brushings and whole blood in nasopharyngeal carcinoma patients before and after treatment. Clin Cancer Res 19:21752186.[PubMed]

Tables

Generic image for table
TABLE 1

Frequency of EBV in non-Hodgkin lymphomas

Citation: Chen D, Yen-Lieberman B. 2016. Epstein-Barr Virus, p 387-398. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch28
Generic image for table
TABLE 2

EBV serological patterns and associated clinical settings

Citation: Chen D, Yen-Lieberman B. 2016. Epstein-Barr Virus, p 387-398. In Loeffelholz M, Hodinka R, Young S, Pinsky B (ed), Clinical Virology Manual, Fifth Edition. ASM Press, Washington, DC. doi: 10.1128/9781555819156.ch28

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error